# Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome

> **NCT04341415** · NA · TERMINATED · sponsor: **Fondation Ophtalmologique Adolphe de Rothschild** · enrollment: 31 (actual)

## Conditions studied

- Covid19
- SARS-CoV Infection

## Interventions

- **PROCEDURE:** Auricular neuromodulation
- **PROCEDURE:** Control

## Key facts

- **NCT ID:** NCT04341415
- **Lead sponsor:** Fondation Ophtalmologique Adolphe de Rothschild
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-09
- **Primary completion:** 2020-11-20
- **Final completion:** 2021-01-15
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** Inclusion stopped at 50% after interim analysis: primary efficacy endpoint not significant
- **Last updated:** 2021-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04341415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04341415, "Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04341415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*